VirtuCell is developing predictive models to support immunology research and therapeutic discovery.
Immune modulating therapies are transforming cancer care, autoimmune conditions, and infectious disease. Yet they remain limited by clinical failures, cost, and toxicity. A key challenge in developing improved immunotherapies is understanding immune cell behavior across diverse biological contexts. That’s one challenge we’re working to address.
VirtuCell brings together deep expertise across immunology, network biology, and computational biology. Our scientific team includes innovators in protein structure prediction, biological network modeling, immune signaling, and translational immunology, alongside experience commercializing emerging life science technologies and building strategic partnerships.
If you're a biopharma R&D leader exploring an early scientific collaboration, a group with complementary capabilities, or a stakeholder interested in AI-for-immunology — we'd like to hear from you.
For inquiries, please include a brief description of your area of interest and the type of conversation you're hoping to have.
By contacting us, you consent to receive follow-up communications from VirtuCell. We respect your inbox.